Cargando…

Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy

T cell dysfunction occurs early following HIV infection, impacting the emergence of non-AIDS morbidities and limiting curative efforts. ART initiated during primary HIV infection (PHI) can reverse this dysfunction, but the extent of recovery is unknown. We studied 66 HIV-infected individuals treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Genevieve E., Sen, Debattama R., Pace, Matthew, Robinson, Nicola, Meyerowitz, Jodi, Adland, Emily, Thornhill, John P., Jones, Mathew, Ogbe, Ane, Parolini, Lucia, Olejniczak, Natalia, Zacharopoulou, Panagiota, Brown, Helen, Willberg, Christian B., Nwokolo, Nneka, Fox, Julie, Fidler, Sarah, Haining, W. Nicholas, Frater, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213372/ https://www.ncbi.nlm.nih.gov/pubmed/34149690 http://dx.doi.org/10.3389/fimmu.2021.647688

Ejemplares similares

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
por: Pace, Matthew, et al.
Publicado: (2022)

Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion
por: Martin, Genevieve E, et al.
Publicado: (2020)

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
por: Martin, Genevieve E., et al.
Publicado: (2018)

Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
por: Hoffmann, Matthias, et al.
Publicado: (2016)

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
por: Fidler, Sarah, et al.
Publicado: (2017)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
por: Zacharopoulou, P., et al.
Publicado: (2022)

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
por: Pace, Matthew, et al.
Publicado: (2016)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
por: Hurst, Jacob, et al.
Publicado: (2015)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
por: Martin, Genevieve E., et al.
Publicado: (2017)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery
por: Thornhill, John Patrick, et al.
Publicado: (2017)

The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection—study protocol for a two-stage randomised phase II trial
por: Lee, Ming Jie, et al.
Publicado: (2022)

A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117
por: Zacharopoulou, Panagiota, et al.
Publicado: (2022)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite Controllers
por: Phetsouphanh, Chansavath, et al.
Publicado: (2019)

Human MAIT cells respond to and suppress HIV-1
por: Phetsouphanh, Chansavath, et al.
Publicado: (2021)

Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection
por: Burns, JE, et al.
Publicado: (2021)

A seat at the table is not enough: a perspective on Black women representation in academia
por: Ogbe, Ane
Publicado: (2022)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
por: Kopycinski, Jakub, et al.
Publicado: (2023)

No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach
por: Alagaratnam, Jasmini, et al.
Publicado: (2021)

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection
por: Fidler, Sarah, et al.
Publicado: (2017)

PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity
por: LaFleur, Martin W., et al.
Publicado: (2019)

CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)

A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England
por: Gourlay, Annabelle, et al.
Publicado: (2017)

Decreased physical performance despite objective and subjective maximal exhaustion in post-COVID-19 individuals with fatigue
por: Vollrath, Shirin, et al.
Publicado: (2023)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP
por: Pilkington, Victoria, et al.
Publicado: (2018)

Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports
por: Fox, Julie, et al.
Publicado: (2016)

Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection
por: Alrubayyi, Aljawharah, et al.
Publicado: (2020)

Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents
por: Jay, Cecilia, et al.
Publicado: (2023)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
por: Fidler, S., et al.
Publicado: (2020)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
por: Frater, John, et al.
Publicado: (2021)

IAS Towards an HIV Cure Symposium: people focused, science driven: 18–19 July 2015, Vancouver, Canada
por: Fidler, Sarah, et al.
Publicado: (2015)

CD4:CD8 ratio in children with perinatally acquired HIV‐1 infection
por: Seers, T, et al.
Publicado: (2018)

Coregulation of CD8(+) T cell exhaustion during chronic viral infection by multiple inhibitory receptors
por: Blackburn, Shawn D., et al.
Publicado: (2008)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

Differentiation of exhausted CD8 T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory
por: Tonnerre, Pierre, et al.
Publicado: (2021)

Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency
por: Hurst, Tara, et al.
Publicado: (2016)

Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
por: McRitchie, Bayley R., et al.
Publicado: (2022)

A Successful Pregnancy Despite the Presence of an Intrauterine Fetal Bone Fragment
por: Petrakis, Evangelos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c4penpn4dt9dh4sm3s0hhni5t6